Charles Schwab’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104M Sell
1,431,504
-75,227
-5% -$4.56M 0.01% 779
2026
Q1
$73.8M Buy
1,506,731
+13,271
+0.9% +$620K 0.01% 901
2025
Q4
$53.7M Buy
1,493,460
+4,301
+0.3% +$174K 0.01% 1110
2025
Q3
$67.5M Sell
1,489,159
-24,599
-2% -$995K 0.01% 956
2025
Q2
$48M Buy
1,513,758
+46,049
+3% +$1.32M 0.01% 1133
2025
Q1
$43.8M Buy
1,467,709
+39,953
+3% +$1.41M 0.01% 1167
2024
Q4
$51.2M Buy
1,427,756
+42,292
+3% +$1.66M 0.01% 1116
2024
Q3
$56.1M Buy
1,385,464
+17,701
+1% +$754K 0.01% 1045
2024
Q2
$64M Buy
1,367,763
+26,041
+2% +$1.14M 0.01% 893
2024
Q1
$56.9M Buy
1,341,722
+45,993
+4% +$1.79M 0.01% 945
2023
Q4
$54.1M Buy
1,295,729
+61,890
+5% +$2.38M 0.01% 918
2023
Q3
$52.4M Buy
1,233,839
+12,167
+1% +$598K 0.02% 844
2023
Q2
$68.4M Sell
1,221,672
-8,943
-0.7% -$463K 0.02% 680
2023
Q1
$61M Buy
1,230,615
+33,686
+3% +$1.7M 0.02% 697
2022
Q4
$56.4M Buy
1,196,929
+58,679
+5% +$2.75M 0.02% 730
2022
Q3
$47.2M Buy
1,138,250
+69,968
+7% +$3.17M 0.02% 796
2022
Q2
$45.4M Buy
1,068,282
+40,599
+4% +$2.28M 0.02% 801
2022
Q1
$79.3M Buy
1,027,683
+43,677
+4% +$2.99M 0.02% 614
2021
Q4
$76.5M Buy
984,006
+26,799
+3% +$2.16M 0.02% 661
2021
Q3
$76.8M Buy
957,207
+32,545
+4% +$2.8M 0.03% 619
2021
Q2
$77.7M Buy
924,662
+27,678
+3% +$2.24M 0.03% 618
2021
Q1
$74.4M Buy
896,984
+4,551
+0.5% +$379K 0.03% 608
2020
Q4
$71.6M Buy
892,433
+20,254
+2% +$1.47M 0.03% 572
2020
Q3
$56.8M Sell
872,179
-70,006
-7% -$4.52M 0.03% 603
2020
Q2
$56.3M Sell
942,185
-19,942
-2% -$1.08M 0.03% 573
2020
Q1
$40.6M Buy
962,127
+40,120
+4% +$2.01M 0.02% 611
2019
Q4
$51.7M Buy
922,007
+20,647
+2% +$1.07M 0.03% 608
2019
Q3
$44.3M Buy
901,360
+38,431
+4% +$1.73M 0.03% 652
2019
Q2
$41.4M Buy
862,929
+32,733
+4% +$1.57M 0.03% 666
2019
Q1
$42.2M Buy
830,196
+57,257
+7% +$2.74M 0.03% 629
2018
Q4
$29.9M Buy
772,939
+32,185
+4% +$1.4M 0.02% 720
2018
Q3
$41.3M Buy
740,754
+43,070
+6% +$2.21M 0.03% 629
2018
Q2
$31.1M Buy
697,684
+44,377
+7% +$2.1M 0.02% 758
2018
Q1
$34M Buy
653,307
+32,552
+5% +$1.92M 0.03% 671
2017
Q4
$38M Buy
620,755
+18,703
+3% +$1.19M 0.03% 576
2017
Q3
$33.2M Sell
602,052
-182,238
-23% -$9.25M 0.03% 593
2017
Q2
$33.3M Buy
784,290
+6,186
+0.8% +$275K 0.03% 547
2017
Q1
$32.7M Buy
778,104
+48,458
+7% +$1.77M 0.03% 537
2016
Q4
$23.2M Buy
729,646
+55,944
+8% +$1.6M 0.03% 659
2016
Q3
$17.8M Buy
673,702
+214,880
+47% +$5.15M 0.02% 761
2016
Q2
$9.89M Buy
458,822
+37,786
+9% +$762K 0.01% 1076
2016
Q1
$8.2M Buy
421,036
+16,020
+4% +$279K 0.01% 1175
2015
Q4
$6.84M Buy
405,016
+19,792
+5% +$353K 0.01% 1308
2015
Q3
$6.62M Buy
385,224
+24,556
+7% +$488K 0.01% 1286
2015
Q2
$8.68M Sell
360,668
-242,622
-40% -$5.96M 0.01% 1154
2015
Q1
$15M Buy
603,290
+42,668
+8% +$907K 0.02% 732
2014
Q4
$11.6M Buy
560,622
+1,752
+0.3% +$34.9K 0.02% 790
2014
Q3
$11.3M Buy
558,870
+19,808
+4% +$409K 0.02% 728
2014
Q2
$10.3M Sell
539,062
-12,610
-2% -$223K 0.02% 806
2014
Q1
$9.34M Buy
551,672
+77,740
+16% +$1.45M 0.02% 854
2013
Q4
$9.05M Buy
473,932
+17,560
+4% +$285K 0.02% 793
2013
Q3
$7.19M Buy
456,372
+15,480
+4% +$217K 0.01% 876
2013
Q2
$5.1M Buy
+440,892
New +$4.69M 0.01% 1032

Other funds holding CGNX

Charles Schwab's CGNX Position: Q2 2026 in Review

Charles Schwab reduced its Cognex (CGNX) stake by 5% in Q2 2026, selling an estimated $4.56M and leaving 1,431,504 shares worth $104M. The position accounts for 0.01% of the portfolio, ranked #779.

Charles Schwab first reported a position in CGNX in Q2 2013 and has held it in 53 quarters since. 649 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Charles Schwab held 1,431,504 shares of Cognex worth $104M as of Q2 2026.
  • Charles Schwab sold 75,227 Cognex shares in Q2 2026, an estimated $4.56M.
  • Cognex made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #779 holding.
  • Charles Schwab first reported a position in Cognex in Q2 2013 and has held it in 53 quarters since.
  • 649 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.